Delay likely as India banks only on local makers for vaccine

India has the capacity and tie-ups to manufacture about 2 billion vaccine doses but its strategy to bank only on local production and not enter into any pre-purchase agreements with multiple global drugmakers could delay the availability of vaccines in the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2KquSe0
via IFTTT